Conference Coverage

Investigational agent could accurately predict memory decline


 

AT AAIC 2014

References

Dr. Johnson has been an adviser or consultant for Siemens Healthcare Diagnostics, Genzyme, and Piramal Healthcare. He has received research funding from Avid Radiopharmaceuticals, Eli Lilly, and other companies.

msullivan@frontlinemedcom.com

On Twitter @alz_gal

Pages

Recommended Reading

VIDEO: Investigative eye amyloid test shines a light on Alzheimer’s pathology
MDedge Neurology
Alzheimer’s disease antibody crenezumab doesn’t deliver in phase II trial
MDedge Neurology
VIDEO: Consider cognitive function in elderly before surgery
MDedge Neurology
Many dementia patients have guns at home
MDedge Neurology
VIDEO: In patients with dementia, ask about guns at home
MDedge Neurology
VIDEO: Dementia risk spikes in older veterans with sleep disorders, PTSD
MDedge Neurology
VIDEO: Lifestyle improvements prevented cognitive decline in at-risk elderly
MDedge Neurology
VIDEO: Late-life hypertension may reduce dementia risk
MDedge Neurology
Widowhood paradoxically does not increase risk of dementia in older adults
MDedge Neurology
TDP-43 could be potential new biomarker for Alzheimer’s disease
MDedge Neurology